| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | 9X5A2QIA7C |
| InChI Key | JLFSBHQQXIAQEC-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C18H15N5O |
| Molecular Weight | 317.35 |
| AlogP | 2.39 |
| Hydrogen Bond Acceptor | 5.0 |
| Hydrogen Bond Donor | 2.0 |
| Number of Rotational Bond | 2.0 |
| Polar Surface Area | 73.38 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 3.0 |
| Heavy Atoms | 24.0 |
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | Poly [ADP-ribose] polymerase-1 inhibitor |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Transferase
|
- | 1-12 | - | - | 2.393-10.75 | |
|
Epigenetic regulator
Eraser
Histone deacetylase
HDAC class IIb
|
- | - | - | - | -8.46--2.74 |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Ovarian Neoplasms | 2 | D010051 | ClinicalTrials |
| Breast Neoplasms | 1 | D001943 | ClinicalTrials |
| Neoplasms | 1 | D009369 | ClinicalTrials |
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL3644587 |
| DrugBank | DB16063 |
| FDA SRS | 9X5A2QIA7C |
| SureChEMBL | SCHEMBL3886731 |
| ZINC | ZINC000059277233 |